Pacific Biosciences Of California (PACB) Property, Plant & Equipment (Net) Growth (1y) (2011 - 2026)
Pacific Biosciences Of California (PACB) Property, Plant & Equipment (Net) Growth (1y) (2011 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | PP&E (Net) Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.92 Bn | 146.27 Bn | 6.27 Bn | 13.22% |
| 2 | Stryker | 119.50 Bn | 116.62 Bn | 3.81 Bn | 9.93% |
| 3 | Medtronic | 102.71 Bn | 94.54 Bn | 5.76 Bn | 8.89% |
| 4 | Boston Scientific | 69.72 Bn | 68.51 Bn | 3.61 Bn | 19.89% |
| 5 | Edwards Lifesciences | 49.24 Bn | 45.57 Bn | 1.29 Bn | 7.35% |
| 6 | GE HealthCare Technologies | 29.74 Bn | 27.67 Bn | 1.98 Bn | 8.56% |
| 7 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn | 1.61% |
| 8 | Dexcom | 28.96 Bn | 27.84 Bn | 750.30 Mn | 14.29% |
| 9 | Steris | 20.31 Bn | 19.88 Bn | 697.10 Mn | 10.46% |
| 10 | Pacific Biosciences Of California | 402.15 Mn | 126.19 Mn | 12.84 Mn | -1.69% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -1.69% |
| Dec 31, 2025 | -20.85% |
| Sep 30, 2025 | -30.75% |
| Jun 30, 2025 | -33.82% |
| Mar 31, 2025 | -33.51% |
| Dec 31, 2024 | -16.27% |
| Sep 30, 2024 | -20.79% |
| Jun 30, 2024 | -13.41% |
| Mar 31, 2024 | -8.67% |
| Dec 31, 2023 | -12.38% |
| Sep 30, 2023 | 3.03% |
| Jun 30, 2023 | 6.22% |
| Mar 31, 2023 | 14.99% |
| Dec 31, 2022 | 27.92% |
| Jun 30, 2022 | 51.83% |
| Mar 31, 2022 | 46.69% |
| Dec 31, 2021 | 30.54% |
| Jun 30, 2021 | -9.85% |
| Mar 31, 2021 | -16.75% |
| Dec 31, 2020 | -17.20% |